WO1992004015A3 - REGULATION DE LA PROLIFERATION DE LYMPHOCYTES T VIA UN NOUVEAU RECEPTEUR, LE 5HT1a - Google Patents
REGULATION DE LA PROLIFERATION DE LYMPHOCYTES T VIA UN NOUVEAU RECEPTEUR, LE 5HT1a Download PDFInfo
- Publication number
- WO1992004015A3 WO1992004015A3 PCT/US1991/006176 US9106176W WO9204015A3 WO 1992004015 A3 WO1992004015 A3 WO 1992004015A3 US 9106176 W US9106176 W US 9106176W WO 9204015 A3 WO9204015 A3 WO 9204015A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell proliferation
- regulation
- novel
- 5ht1a receptor
- proliferation via
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/286—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3517820A JPH06503816A (ja) | 1990-09-04 | 1991-09-04 | 新規な5HT1a受容体を介するT細胞増殖の調節 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57871090A | 1990-09-04 | 1990-09-04 | |
US578,710 | 1990-09-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1992004015A2 WO1992004015A2 (fr) | 1992-03-19 |
WO1992004015A3 true WO1992004015A3 (fr) | 1992-04-16 |
Family
ID=24313971
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/006175 WO1992004014A2 (fr) | 1990-09-04 | 1991-09-04 | Regulation de la proliferation de cellules neoplasiques par l'intermediaire d'un nouveau recepteur 5ht1a |
PCT/US1991/006176 WO1992004015A2 (fr) | 1990-09-04 | 1991-09-04 | REGULATION DE LA PROLIFERATION DE LYMPHOCYTES T VIA UN NOUVEAU RECEPTEUR, LE 5HT1a |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1991/006175 WO1992004014A2 (fr) | 1990-09-04 | 1991-09-04 | Regulation de la proliferation de cellules neoplasiques par l'intermediaire d'un nouveau recepteur 5ht1a |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP0547172A1 (fr) |
JP (2) | JPH06503816A (fr) |
AU (2) | AU8848291A (fr) |
CA (2) | CA2090689A1 (fr) |
WO (2) | WO1992004014A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5461054A (en) * | 1993-12-09 | 1995-10-24 | Bayer Aktiengesellschaft | Anthracene-spiro-pyrrolindines |
US5411960A (en) * | 1993-12-09 | 1995-05-02 | Bayer Aktiengesellschaft | Substituted pyrroloanthracenes and -diones |
US5409932A (en) * | 1993-12-09 | 1995-04-25 | Bayer Ag | Piperazine-substituted pyrroloanthracenes |
AU2880495A (en) * | 1994-07-06 | 1996-01-25 | Bo Arne Hofmann | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses |
WO1996001107A1 (fr) * | 1994-07-06 | 1996-01-18 | Bo Arne Hofmann | Emploi d'agents pharmaceutiques retablissant, ameliorant ou traitant la deficience immunitaire et notamment ameliorant ou traitant certains troubles immunitaires lies a des infections par le vih |
EP0813878B1 (fr) * | 1996-06-17 | 2002-02-06 | Mitsubishi Chemical Corporation | Agent pour accélérer la lacrimation contenant un ligand de la sérotonine, particuliérement un composé aminoalkoxybibenzyle |
WO2002078643A2 (fr) | 2001-03-30 | 2002-10-10 | Philadelphia Health And Education Corporation | Immunomodulation et action sur des processus cellulaires relatifs aux recepteurs de la famille de la serotonine |
KR101519028B1 (ko) * | 2007-04-13 | 2015-05-11 | 써던 리서취 인스티튜트 | 항혈관형성제 및 사용방법 |
CN113599370B (zh) * | 2021-08-03 | 2023-12-08 | 复旦大学附属肿瘤医院 | 8-oh-dpat及其衍生物在制备抗肿瘤药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991002527A1 (fr) * | 1989-08-21 | 1991-03-07 | Beth Israel Hospital Association | Procede et composition de traitement d'hypersensibilite cutanee, oculaire et des muqueuses, d'etats inflammatoires et hyperproliferatifs en utilisant des preparations topiques d'antagonistes de serotonine |
-
1991
- 1991-09-04 AU AU88482/91A patent/AU8848291A/en not_active Abandoned
- 1991-09-04 CA CA002090689A patent/CA2090689A1/fr not_active Abandoned
- 1991-09-04 EP EP91918533A patent/EP0547172A1/fr not_active Withdrawn
- 1991-09-04 EP EP91915814A patent/EP0555231A1/fr not_active Withdrawn
- 1991-09-04 AU AU84998/91A patent/AU8499891A/en not_active Abandoned
- 1991-09-04 CA CA002090688A patent/CA2090688A1/fr not_active Abandoned
- 1991-09-04 JP JP3517820A patent/JPH06503816A/ja active Pending
- 1991-09-04 WO PCT/US1991/006175 patent/WO1992004014A2/fr not_active Application Discontinuation
- 1991-09-04 JP JP3514697A patent/JPH06500775A/ja active Pending
- 1991-09-04 WO PCT/US1991/006176 patent/WO1992004015A2/fr not_active Application Discontinuation
Non-Patent Citations (4)
Title |
---|
Eur. J. Pharmacol., vol. 170, no. 1/2, October 1989, Elsevier Science Publishers B.V., Amsterdam (NL), M. Pranzatelli et al.: "Identification of 5-HT1A recognition sites in human ganglioneuroblastoma", pages 127-128, see the whole article * |
J. Immunol., vol. 145, no. 6, 15 September 1990, Baltimore (US), T. Aune et al.: "Serotonin-activated signal transduction via serotonin receptors on Jurkat cells", pages 1826-1831, see the whole article * |
N. Engl. J. Med., vol. 277, no. 21, 23 November 1967, Boston (US), K. Engelman et al.: "Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome", pages 1103-1108, see page 1108, lines 13-32 * |
Proc. Natl. Acad. Sci, USA, vol. 82, no. 2, January 1985, Washington DC, (US) R. Todd et al.: "Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child", pages 612-616, see the abstract * |
Also Published As
Publication number | Publication date |
---|---|
JPH06500775A (ja) | 1994-01-27 |
WO1992004015A2 (fr) | 1992-03-19 |
WO1992004014A2 (fr) | 1992-03-19 |
EP0555231A1 (fr) | 1993-08-18 |
AU8848291A (en) | 1992-03-30 |
CA2090688A1 (fr) | 1992-03-05 |
WO1992004014A3 (fr) | 1992-05-14 |
AU8499891A (en) | 1992-03-30 |
CA2090689A1 (fr) | 1992-03-05 |
JPH06503816A (ja) | 1994-04-28 |
EP0547172A1 (fr) | 1993-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6226494A (en) | Spiroazacyclic derivatives as substance p antagonists | |
SG48225A1 (en) | Styryl-substituted heteroaryl compounds which inhibit for receptor tyrosine kinase | |
MY118556A (en) | Catalytic composition suitable for the fischer-tropsch process | |
ES8801790A1 (es) | Un procedimiento para la preparacion de derivados de indol | |
CA2137793A1 (fr) | Cristallisation de m-csf | |
MD1632F2 (en) | Bicyclic compounds, method of inhibiting the tyrosine kinases receptors as epidermal growth factor, pharmaceutical composition, methods of preventing blastocyte implantation and treatment of mammals | |
WO1992004015A3 (fr) | REGULATION DE LA PROLIFERATION DE LYMPHOCYTES T VIA UN NOUVEAU RECEPTEUR, LE 5HT1a | |
EP0354777A3 (fr) | Dérivés du 3-(4-pipéridine)-5-(2-sulfonylaminoéthyl)-indole | |
EP0351112A3 (fr) | Composé photochromique, procédé de préparation, son application et composition photochromique le contenant | |
AU558375B2 (en) | 6-(7-)-oxy-trans-1,2,3,4,4a,5,10,10a-octahydrobenzo (g)quinolines | |
MX9801890A (es) | Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen. | |
TW248566B (fr) | ||
NZ333018A (en) | Derivatives of K-252a (indolocarbazole derivatives) and use thereof | |
DK616084D0 (da) | Inaktivt bindemiddel paa basis af polycaprolacton til et gennem munden indgiveligt laegemiddel samt fremgangsmaade til fremstilling af en blanding omfattende bindemidlet | |
AU2736495A (en) | Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites | |
ES8800214A1 (es) | Procedimiento para preparar derivados de bencimidazol substituidos | |
AU6693694A (en) | Material primarily for sport-shooting ammunition | |
ATE288485T1 (de) | Monoklonaler antikörper 4g8b4b12 gegen humanes flt3/flk2 | |
ES8600740A1 (es) | Un procedimiento para la preparacion de nuevos derivados de isoindol | |
ATE169949T1 (de) | Bindemittelsysteme für die elektrotauchlackierung | |
AU572136B2 (en) | 1-(4'-branched alkylsulfonylphenyl)-6-chloro-7,8-dihydroxy- 2,3,4,5-tetrahydro-1h-3-benazepines | |
ES8205218A1 (es) | Un procedimiento para la preparacion de pirrolilpiperidinas utiles como agentes antidepresivo. | |
IL64319A (en) | Plant growth regulating compositions containing bicyclo(2.2.1)heptane-2-oxime derivatives,certain such novel compounds and their preparation | |
ES2013391A6 (es) | Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles. | |
AU7830581A (en) | Feeding of melatonin or related indoles or indole derivatives for purpose of regulating the reproducive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1991918533 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2090689 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1991918533 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1991918533 Country of ref document: EP |